Home » Topics » Regulatory

Regulatory
RSS

Lexapro approved for treatment and maintenance treatment of major depressive disorder

Sep. 2, 2002

E.U. approval for Visudyne

Sep. 2, 2002

Neulasta approved in E.U.

Aug. 30, 2002

E.U. approval for Aranesp

Aug. 29, 2002

Ortho Tri-Cyclen Lo receives FDA approval

Aug. 26, 2002

FDA approves pediatric labeling of Prevacid

Aug. 9, 2002

Lescol sNDA filed for secondary prevention of cardiovascular events in angioplasty patients

Aug. 9, 2002

Risperdal Consta approved in Germany

Aug. 5, 2002

Levaquin sNDA submitted for chronic bacterial prostatitis

Aug. 1, 2002

Eligix CD8-SC Cell Separation System approved in E.U.

Aug. 1, 2002

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.